Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-cash Items (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Non-cash Items for 2 consecutive years, with $43.9 million as the latest value for Q4 2020.

  • Quarterly Non-cash Items rose 751.08% to $43.9 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $43.9 million through Dec 2020, up 751.08% year-over-year, with the annual reading at $43.9 million for FY2020, 751.08% up from the prior year.
  • Non-cash Items for Q4 2020 was $43.9 million at Pliant Therapeutics, up from $45033.0 in the prior quarter.
  • The five-year high for Non-cash Items was $43.9 million in Q4 2020, with the low at $45033.0 in Q3 2020.